Beiley biofund (倍利生技創投), backed by Fubon Securities and tech leaders like Sunplus and Topco, is set to list on the Emerging Stock Market on Dec 9 with a reference price of NT$15.5. Chairman Hsien-hua Huang describes the firm as an "Active ETF" for biotech, offering investors professional oversight in a complex sector.
Read more
